Common clinical indications

• Hemophilia B (congenital factor IX deficiency)
• On-demand treatment and control of bleeding episodes
• Perioperative management
• Routine prophylaxis to decrease frequency of bleeding

Related drugs in this category

• Factor VIIa, recombinant · Eptacog alfa (activated)
• Factor X Human · Coagulation factor X (human)
• Factor XIII Concentrate, Human · Coagulation factor XIII concentrate (human)

Frequently asked questions

What is Factor IX (Recombinant), Fc Fusion Protein used for?

Factor IX (Recombinant), Fc Fusion Protein (Eftrenonacog alfa) is listed in YMed Atlas under Hemostatic. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?

Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.

Is this medical advice?

No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.